Bayer Kogenate FS

Attention: Your browser does not support Javascript, or Javascript support has been disabled. This web site utilizes the latest Internet technology, and in order to experience the full functionality of this web site you will need to ensure that Javascript is enabled.








































	General Conditions of Use Privacy Statement Imprint

	This website is intended for U.S. Audiences Only.

	© 2008 Bayer HealthCare LLC BAYER, the Bayer Cross, and Kogenate are registered trademarks of Bayer BIO-SET is a trademark of Biodome SAS

Kogenate^® FS Antihemophilic Factor (Recombinant) (rFVIII)

As one of the industry leaders in rFVIII manufacturing, Bayer HealthCare is at the forefront in offering the latest advancements in hemophilia treatment. With a 2.5 mL or 5 mL diluent volume in all vial sizes, one of the lowest volumes of any recombinant Factor VIII therapy, for convenient infusions without compromising efficacy, and no albumin used in the final formulation, Kogenate FS takes hemophilia A treatment to a new level.

Building on more than 19 years of history without a single confirmed virus transmission, Kogenate FS offers an extra margin of confidence, made possible with a sucrose formulation - all in a safe dose. Developed and manufactured exclusively by Bayer HealthCare, Kogenate FS is a prime example of our continued investment in the advancement of hemophilia A treatment.

For additional clinical and technical data please contact Bayer Clinical Communications at 1-800-288-8371.

For all other questions, please contact Bayer Customer Service at 1-888-606-3780.

Kogenate® FS, Antihemophilic Factor (Recombinant), is a recombinant factor VIII treatment indicated for the treatment of hemophilia A. The most frequently reported adverse events were local injection site reactions, dizziness, and rash. Known intolerance or allergic reactions to constituents of the preparation is a contraindication to the use of Kogenate® FS. Known hypersensitivity to mouse or hamster protein may be a contraindication to the use of Kogenate® FS. For important safety and use information, please see the full prescribing information.

Please consult your health care provider prior to making any lifestyle changes. The images used on this site do not necessarily represent actual Hemophilia patients.